In utero teratogen exposure and cardiometabolic risk in 5-year-old children: a prospective pediatric study

J J A De Smidt1, H J Odendaal2, D G Nel3

  • 1Department of Medical Biosciences, University of the Western Cape, South Africa.

Insights

Maternal smoking and alcohol consumption during pregnancy are linked to increased intima-media thickness (IMT), a marker of cardiometabolic risk, in 5-year-old children. This study highlights the long-term cardiovascular impact of prenatal teratogen exposure.

Area of Science:

  • Cardiovascular Health
  • Pediatric Health
  • Prenatal Development

Background:

  • Intima-media thickness (IMT) of the aorta and carotid arteries serves as a key indicator of subclinical atherosclerosis and cardiometabolic risk in children.
  • The prenatal environment, influenced by maternal factors like smoking and alcohol use, can program cardiometabolic risk factors in offspring.
  • DNA methylation is a mechanism through which maternal lifestyle choices during pregnancy can affect fetal cardiovascular development.

Purpose of the Study:

  • To investigate the association between maternal smoking and alcohol consumption during pregnancy and the intima-media thickness (IMT) of 5-year-old children in a low-income population.
  • To identify early indicators of cardiometabolic risk in children exposed to dual teratogens in utero.

Main Methods:

  • A cohort of 500 mother-child pairs was followed from pregnancy through the child's fifth year, with data collected at antenatal visits, birth, and age 5.
  • Anthropometric measurements, blood pressure, heart rate, and ultrasound-based IMT of the aorta and carotid arteries were assessed at age 5.
  • Statistical analyses explored the effect of dual *in utero* exposure (maternal smoking and alcohol consumption) on IMT, considering factors like sex and birth weight.

Main Results:

  • Children exposed to both maternal alcohol and nicotine *in utero* exhibited significantly higher carotid intima-media thickness (cIMT) at age 5 (p = .008).
  • Dual *in utero* exposure, male sex, and low birth weight were independently associated with increased cIMT and aorta IMT.
  • Maternal adiposity (BMI and MUAC) showed a positive correlation with right cIMT, while child's BMI at age 5 correlated with blood pressure.

Conclusions:

  • Prenatal exposure to both maternal smoking and alcohol consumption is associated with the presence of cardiometabolic risk factors by age 5.
  • Higher IMT at age 5 is also linked to maternal adiposity, male sex, and low birth weight, underscoring multifactorial influences on early cardiovascular health.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
156
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.8K